RxDoctor Payments Data

Lacey Martin, PA

Physician Assistant · Casper, WYNPI 1639887011

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 31.6% of the total. Among physician assistant clinicians in WY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,435in general payments, 2019–2025

Across 169 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • AbbVie$920
  • Johnson & Johnson$405
  • Sanofi$217
  • Madrigal Pharmaceuticals$146
  • Gilead$102
  • plus $559 from 16 others

What the payments were for

  • Food & beverage$3,435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,435 in reported general payments places this provider in the 95th percentile of 203 physician assistant providers in Wyoming.

See all physician assistant providers in Wyoming

Medicare billing

Part B allowed, 2024
$66,986
Medicare patients
409
Services billed
1,373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase12$46,839
LinzessLinaclotide36$31,986
Mesalamine45$16,007
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates121$8,301
Dexlansoprazole DrDexlansoprazole13$4,044
Famotidine151$3,211
Mesalamine ErMesalamine16$2,334
Pantoprazole Sodium182$2,200
SutabSod Sulf/Pot Chloride/Mag Sulf12$1,933
SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag15$1,836
Sucralfate58$1,681
CholestyramineCholestyramine (With Sugar)18$905
Omeprazole50$612
Sulfasalazine24$379
Ondansetron OdtOndansetron14$303

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$920$78,82548 claims
Braintree Laboratories, Inc.Sutab, Suflave$29$3,76927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 203 physician assistant providers in Wyoming.

Other physician assistant in Casper

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →